EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evidence of an immune system to brain communication axis that affects central opioid functions muramyl peptides attenuate opiate withdrawal


European Journal of Pharmacology 141(2): 253-260
Evidence of an immune system to brain communication axis that affects central opioid functions muramyl peptides attenuate opiate withdrawal
Myramyl peptides are metabolic breakdown products of bacterial cell walls formed in vivo by the reticuloendothelial system. These agents have a variety of immune modulatory and neuropharmacologic effects. It has previously been demonstrated that a variety of immune modifying agents can induce alterations in certain behaviors elicited by opiates. In the present study we investigate possible reciprocal interactions between muramyl dipeptides (MDPs) and central opioid systems using three different experiment models: (1) naloxone-precipitated withdrawal behavior in morphine-dependent rats; (2) the tail immersion assay for determination of morphine-induced antinociception and (3) rectal temperature measurement of the pyrogenic activity of MDP. It is shown that two derivatives of MDP attenuate the severity of naloxone-precipitated withdrawal and morphine-induced antinociception. In addition, it is demonstrated that the pyrogenic activity of a stearoyl derivative of MDP is altered by chronic morphine treatment. These findings suggest both novel neuropharmacologic properties of muramyl dipeptides, as well as demonstrate that yet another immune modifier interacts with centrally mediated opioid phenomena.

Accession: 005411237

PMID: 2824218

DOI: 10.1016/0014-2999(87)90270-6

Download PDF Full Text: Evidence of an immune system to brain communication axis that affects central opioid functions muramyl peptides attenuate opiate withdrawal



Related references

Evidence that opiate addiction is in part an immune response. Destruction of the immune system by irradiation-altered opiate withdrawal. Neuropharmacology 25(8): 815-818, 1986

The brain and the immune system specifically restored immune system is essential for the manifestation of the withdrawal syndrome of opiate dependent rats. Society for Neuroscience Abstracts 12(1): 339, 1986

The brain and the immune system an intact immune system is essential for the manifestation of withdrawal in opiate addicted rats. Neuroscience 36(2): 285-290, 1990

Evidence for internalization of opioid peptides but not opiate drugs in brain slices. Proceedings of the Western Pharmacology Society 27: 363-366, 1984

Evidence of neuro-immunologic interactions: cyclosporine modifies opiate withdrawal by effects on the brain and immune components. Journal of Neuroimmunology 13(3): 331-342, 1987

Central interaction of the brain atrial natriuretic polypeptide (ANP) system and the brain renin-angiotensin system in ANP secretion from heart--evidence for possible brain-heart axis. Canadian Journal of Physiology and Pharmacology 66(3): 255-261, 1988

The immune system and opiate withdrawal. International Journal of Immunopharmacology 11(4): 371-376, 1989

Visualization of opiate receptors and opioid peptides in sequential brain sections. Life Sciences 31(12-13): 1347-1350, 1982

Opiate mediated behaviors and brain opioid peptides in neonates after prenatal ethanol. Society for Neuroscience Abstracts 14(2): 1156, 1988

Accelerated communication: Further evidence that naloxone acts as an inverse opiate agonist: Implications for drug dependence and withdrawal. Life Sciences 58(26): PL381-PL389, 1996